Main Session
Sep
30
SS 33 - GI 2: Giving radiation a boost in pancreatic cancer and responding to the call for esophageal cancer
293 - Patient-Specific TP53-Mutant Circulating Tumor DNA as a Prognostic Biomarker for Detection of Minimal Residual Disease after Neoadjuvant Concurrent Chemoradiotherapy followed by Esophagectomy in Local
Presenter(s)
Jason Chia-Hsien Cheng, MD, PhD, MS, FASTRO - National Taiwan University Hospital, Taipei, Taipei